SPARK Fellows attend biweekly educational sessions to discuss their projects with experts. While these events typically take place behind closed doors, some of the educational seminars are open to the public. Whether you are accepted into SPARK or not, have a new innovation or invention, or are just curious about technology development and commercialization, please follow SPARK's calendar for announcements and updates regarding educational seminars and other events. Events are continuously being added updated so make sure to check back again next week!
SPARK Session 17 | New approaches to drug development and target identification: use of AI
05:00 PM - 07:00 PM
Fulginiti Pavilion for Bioethics and Humanites
13080 East 19th Avenue
Sara Omlid, PhD
Partnering Executive, AtomWise
Sara Omlid, Phd is a Partnering Executive at Atomwise Inc., a biotechnology company in San Francisco that uses artificial intelligence for preclinical drug discovery and development.
Atomwise partners with companies and academic institutions on hit discovery and lead optimization projects. Dr. Omlid manages Atomwise’s successful and rapidly growing Artificial Intelligence Molecular Screen (AIMS) Awards program, which provides AI-powered virtual screening and compounds for testing to over a hundred academic researchers across the world each year.
Prior to joining Atomwise, Dr. Omlid was developing new chemistries to add to the medicinal chemist’s toolbox. She also has experience in management consulting in the biotech and life sciences industry. Dr. Omlid received her PhD and MS in physical organic chemistry as well as her bachelor’s degree in biochemistry from Saint Louis University.